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Blood culture–negative endocarditis is common in
Algeria. We describe the etiology of infective endocarditis
in this country. Samples from 110 cases in 108 patients
were collected in Algiers. Blood cultures were performed in
Algeria. Serologic and molecular analysis of valves was
performed in France. Infective endocarditis was classified
as definite in 77 cases and possible in 33. Causative
agents were detected by blood cultures in 48 cases. All 62
blood culture–negative endocarditis cases were tested by
serologic or molecular methods or both. Of these, 34 test-
ed negative and 28 had an etiologic agent identified. A total
of 18 infective endocarditis cases were caused by zoonot-
ic and arthropodborne bacteria, including Bartonella quin-
tana (14 cases), Brucella melitensis (2 cases), and Coxiella
burnetii (2 cases). Our data underline the high prevalence
of infective endocarditis caused by Bartonella quintana in
northern Africa and the role of serologic and molecular
tools for the diagnosis of blood culture–negative endo-
carditis.
I
n Algeria, infective endocarditis is common. Vegetations
graft primarily on lesions of rheumatic heart disease
(1,2). The rate of blood culture–negative endocarditis in
Algeria is as high as 76% (2), which leads to difficulty in
antimicrobial treatment. Most cases of blood culture–neg-
ative endocarditis have been thought to be caused by pre-
vious antimicrobial therapy. Infective endocarditis
prognosis is often obscured by delayed diagnosis and a
lack of specific treatment. In Algeria, poor socioeconomic
level and lack of medical follow-up of patients are among
the factors associated with endocarditis. The concentration
of medical infrastructures in the northern part of the coun-
try leads to the referral of patients with serious illnesses,
such as endocarditis, to northern hospitals, especially with-
in Algiers (Figure 1). Algiers, the capital and largest city
with ≈5 million inhabitants, has 7 hospitals, including 6
cardiology and 5 cardiac surgery wards. These wards
receive patients with endocarditis, either for diagnosis and
treatment or for corrective surgery of postendocarditis
lesions. A retrospective analysis of Algerian infective
endocarditis cases showed streptococci and staphylococci
were the leading causes, followed by less frequent causes,
such as enterobacteria and Haemophilus spp. (2). A high
percentage of blood culture–negative endocarditis was
noted. However, no study has evaluated the agents respon-
sible for blood culture–negative endocarditis. New sero-
logic and molecular tools, which have improved the
etiologic diagnosis of infective endocarditis, have not been
used to clarify the unknown role of fastidious bacteria
(3–11). In our study, samples were collected from 110
patients with suspected cases of endocarditis. All samples
were analyzed prospectively by using conventional micro-
biologic methods in Algiers. When available, cardiac
valves and serum samples were stored to perform retro-




Clinicians usually diagnose infective endocarditis by
using the modified Duke criteria, which includes 3 major
criteria (blood cultures typical of infective endocarditis,
vegetations on echocardiography, and Coxiella burnetii
serologic testing with immunoglobulin [Ig] G phase I titer
>1:800) and 7 minor criteria (positive blood cultures,
fever, previous heart disease, arterial embolism, positive
results on serologic examination for endocarditis bacterial
pathogens, immunologic disorders, and atypical but com-
patible findings on echocardiography) (12). Definite infec-
tive endocarditis is diagnosed if any of the following
conditions is met: 2 major criteria exist; 1 major criterion
and 3 minor criteria; or 5 minor criteria. Possible infective
endocarditis is considered if 1 major criterion and 1 minor
criterion or 3 minor criteria exist. On the basis of these
criteria, we could locate 110 cases in 108 patients with
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wards and 2 cardiac surgery wards in Algiers during a 42-
month period (June 2000–December 2003). For each
patient, an information sheet with epidemiologic, clinical,
echocardiographic, and biologic data was filled out. Amin-
imum of 3 blood cultures were sampled per patient. Thirty-
eight cardiac valve specimens from 38 (35.4%) patients
were sampled and stored at –80°C. Thirty-seven cardiac
valve specimens from another 30 (27.3%) patients were
formalin-fixed for pathologic testing. Sixty-one serum
samples from 61 (55.5%) patients were available.
Blood Cultures
Either Castaneda Aer/Anaer (Bio-Rad, Marnes-La-
Coquette, France) or broth for blood culture (Institut
Pasteur d’Algérie, Algiers, Algeria) were used as blood-
culture medium and were incubated at 37°C. If signs of
culture appeared, a blood sample was taken from the cul-
ture bottle and Gram staining on Columbia blood agar
(BioMérieux, Marcy L’Etoile, France) and chocolate agar
(BioMérieux) was performed. Agar plates were incubated
in 5% CO2 at 37°C. In the event of culture, the microor-
ganism was identified by API identification tests
(BioMérieux). At day 15 of incubation, if cultures
remained negative, an enrichment of each bottle was
processed on Todd-Hewitt broth (Institut Pasteur
d’Algérie) supplemented with 0.01% L-cysteine (Sigma-
Aldrich, Lausanne, Switzerland) and 0.001% hypochloride
pyridoxal (Sigma-Aldrich). In cases of broth turbidity,
microscopic examinations were performed as described
above. If culture was positive, the strain was identified.
Valve Analysis
Axenic Culture
Thirty-eight excised cardiac valves were examined. If
macroscopic lesions of infective endocarditis were detect-
ed, we attempted to divide the valve into 3 parts to be used
for bacteriologic analysis, storage at –80°C, and histologic
analysis. Portions of valve tissue were ground with a mor-
tar and pestle and cultured on Columbia blood agar and
chocolate agar supplemented with Polyvitaminic
Supplement (Bio-Rad) at 35°C for 15 days in 5% CO2. We
performed direct Gram staining and identified colonies as
described above. 
Cell Culture
Cell cultures were performed in France. Specimens
from 12 cardiac valves positive on polymerase chain reac-
tion (PCR) for Bartonella quintana or Brucella melitensis
were spread onto cells grown within a shell vial as previ-
ously described (13,14). After 3 weeks of incubation at
37°C, the bacteria were detected by using Gimenez stain-
ing, a direct immunofluorescence test incorporating poly-
clonal antibodies directed against Bartonella, and by PCR
targeting the 16S rRNA sequence.
Molecular Biology
For the 38 cardiac samples stored at –80°C, molecular
analysis was performed in France. After 18 hours of pro-
teinase K digestion at 55°C, DNA was extracted from tis-
sue by using the MagNA Pure LC instrument (Roche
Molecular Biochemicals, Manheim, Germany) and
MagNA Pure LC DNA Isolation Kit III (Roche Molecular
Biochemicals), as described by the manufacturer. A PCR-
positive valve sample taken from a patient with
Staphylococcus aureus endocarditis was used as a positive
control. A mixture of all reagents used for DNA extraction
and DNA extracted from normal heart tissue were
processed as negative controls. One negative control was
included for every 5 samples tested. PCR amplification
and sequencing were performed, as previously described
(15), by using primers in Table 1. PCR targeting the 16S
rRNA sequence was systematically performed. When a
negative result occurred, additional PCR was performed
targeting the 18S and 28S rRNA internal transcribed spac-
er to search for fungal infections. All positive PCR prod-
ucts were sequenced. The sequences were compared to
those available in GenBank. Positive PCR results were
considered as certain, when congruence existed between
the results obtained with PCR and those obtained with
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Figure 1. Map of Algeria. Courtesy of Wikipedia Encyclopedia
(http://en.wikipedia.org/wiki).other analyses. With a positive result interpreted as a pos-
sible case, we performed additional PCR, targeting a sec-
ond gene with genus-specific primers (Table 1). When the
PCR was positive and the sequence gave the same result,
the case was reclassified as certain. When the second PCR
was negative, we performed a PCR targeting a third gene.
When both PCRs targeting the second and the third gene
were negative, the result was classified as negative. 
Histologic and Immunohistologic Analysis
Thirty-seven valve samples underwent fixation by for-
malin and were paraffin-embedded. Valve specimens were
cut to 3-µm thickness serial sections. Hematoxylin-eosin-
saffron, periodic acid-Schiff, Giemsa, Brown-
Hopps/Brown-Brenn Gram, Grocott-Gomori methena-
mine silver, and Warthin-Starry stains were used (16). On
the basis of the histologic findings, valve specimens were
divided into 3 groups: A, B, and C. Group A samples
showed histologic features of infective endocarditis con-
sisting of vegetations or polymorphonuclear leukocyte–
rich valvular inflammation. Group B specimens showed
valvular inflammation composed of mainly inflammatory
mononuclear cells, macrophages, and lymphocytes with-
out vegetations and microorganisms. Group C samples
were devoid of inflammation, vegetations, or microorgan-
isms. When Bartonella endocarditis was suspected,
immunohistochemical analysis was performed on valve
sections with an anti-Bartonella rabbit polyclonal antibody
as previously described (17). 
Serum Sample Analysis
Serologic Testing
Brucella serologic analysis was performed by Rose-
Bengale agglutination (Bio-Rad, Marnes-La-Coquette,
France) for 61 serum samples from 61 patients in Algiers,
and the samples were stored at –20°C for further study.
The confirmation was observed by Wright Serology (Bio-
Rad). In the case of endocarditis, specific antibody titers
exceeded 1:800. Bartonella and C. burnetii serologic test-
ing was performed in France on all 61 samples. For
Bartonella serologic testing, B. quintana and B. henselae
were used as antigens in a microimmunofluorescence
(MIF) assay performed as previously described (18). A
patient was considered to have Bartonella endocarditis
when IgG titers >1:800 were observed (18). The species
identification was performed with Western blot performed
before and after serum cross-adsorption as previously
described (19). For C. burnetii serologic testing,
immunoglobulin (Ig) G, IgM, and IgA antibody titers were
estimated by using an MIF test as previously described
(20). A diagnosis of chronic endocarditis was made when
a patient had an IgG phase I titer >1:800 (20). A Light
Cycler nested PCR was performed on positive serum sam-




Our prospective study led to identification of 110 cases
from 108 patients. The 110 episodes were classified as 77
(70%) definite infective endocarditis and 33 (30%) possi-
ble infective endocarditis (12). A second episode of infec-
tive endocarditis developed in 2 patients during our survey.
The patients included 64 men and 40 women with a mean
age of 35.3 years (range 17–72 years). The series included
4 children, 2 boys (6 and 8 years of age) and 2 girls (9 and
14 years of age). Among the patients, 34 came from rural
areas, 61 lived in urban areas, 1 was in prison, and no
information could be obtained for 12. Among 96 patients
whose living conditions were known, 59 (61.5%) lived in
poor and crowded families of at least 10 persons. Among
the 110 cases, 87 (79%) episodes were diagnosed on native
valve and 23 (21%) on prosthetic valve. The mitral valve
was affected in 31 (28.2%) cases, the aortic in 29 (26.3%),
and both in 41 (37.2%). The tricuspid valve was affected
in 3 (2.7%) patients, and 4 (3.6%) had aortic, mitral, and
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pulmonary valves affected, with the persistence of an arte-
rial canal, and 1 patient on a pacemaker. 
Blood Cultures
Blood cultures identified 48 microorganisms (Table 2).
Of the 22 Streptococcus spp. cultures, 5 Streptococcus
mitis, 6 Streptococcus sp., 3 S. agalactiae, 3
Granulicatella adiacens, 2 α-Streptococcus, 1 S. oralis, 1
S. intermedius, and 1 Gemella morbillorum were identi-
fied. Seven Staphylococcus aureus and 5 coagulase-nega-
tive  Staphylococcus were observed. One Haemophilus
influenzae, 1 H. aphrophilus, 1 Haemophilus sp., 1
Kingella kingae, and 1 Actinobacillus actinomycetemcomi-
tans were identified among the HACEK group
(Haemophilus,  Actinobacillus,  Cardiobacterium,
Eikenella, Kingella.). One Brucella melitensis, a zoonotic
agent, was isolated. 
Serum Analysis
Using serologic testing, infective endocarditis could be
diagnosed in 11 (18%) of 61 serum samples. A positive
Brucella serologic result with titers of 1:3,200 was
observed for 2 patients (1 sample was also culture posi-
tive). Two other patients had a typical profile of Q fever
endocarditis (Phase I: IgG 1:3,200; IgM 1:25; IgA
1:1,600/Phase II: IgG 1:6,400; IgM 1:25; IgA 1:1,600 for
1 patient and Phase I: IgG 1:6,400; IgM 1:800; IgA
1:50/Phase II: IgG 1:12,800; IgM 1:800; IgA1:100 for the
other patient). Among these 2 patients, C. burnetii Light
Cycler nested-PCR performed on serum samples was
positive for the sample from 1 patient. A positive
Bartonella serologic result, with IgG >1:800, was
observed for 7 patients (Table 3). The Western-blot analy-
sis of the 7 serum samples allowed the specific diagnosis
of B. quintana (Figure 2). Of these 7 patients, B. quintana
Light Cycler nested-PCR performed on serum samples
was positive for 5 patients (Table 3). 
Cardiac Valve Analysis
Axenic culture of cardiac valves was positive for 9
samples. The growth of 2 coagulase-negative
Staphylococcus, 2 Streptococcus sp., 1 Staphylococcus
aureus, 1 Streptococcus mitis, 1 S. intermedius, 1
Corynebacterium sp., and 1 Candida kruzei was observed.
Another sample was polymicrobial. Cell culture allowed
the growth of B. quintana, an arthropodborne disease
agent, from 3 valve samples (Tables 2 and 3). The num-
bers of valve specimens classified into groups A, B, and C
were 21, 5, and 11, respectively. With the exception of
Bartonella endocarditis, the samples with histologic fea-
tures of infective endocarditis had vegetations in most
cases, moderate fibrosis, calcifications in some cases, and
numerous inflammatory infiltrates composed predomi-
nantly of polymorphonuclear leukocytes and abundant
neovascularization. By using special stains, microorgan-
isms were visualized in 16 samples from group A, gram-
positive cocci and gram-negative bacilli in 8 cases each.
In samples from group B, the inflammatory infiltrates
were rare and focal and consisted mainly of macrophages
and lymphocytes with discrete neovascularization. The
specimens from group C showed noninflammatory
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calcifications. The histologic features of Bartonella endo-
carditis were different from the other infective endocardi-
tis. Samples from 7 cases with Bartonella endocarditis
were examined. The valve tissues showed degenerative
damage with extensive fibrosis. The valve tissues were
poorly inflamed with rare mononuclear inflammatory cell
infiltrates composed of lymphocytes and macrophages
and discrete neovascularization. Vegetations, present in
all samples, were small in size. In all cases, the Warthin-
Starry stain detected Bartonella, mainly in vegetations as
small bacillary organisms (Figure 3). 
The 16S rRNA PCR was positive for 29 cardiac valves
(Tables 2 and 4). B. quintana was detected on 10 speci-
mens (Table 3). Among the Streptococcus spp. and related
genera, 3 Streptococcus sp., 1 S. mitis, 1 S. mutans, 1 S.
gordonii, 1 S. pneumoniae, and 1 Granulicatella adiacens
were detected. Two Staphylococcus aureus and 1 coagu-
lase-negative Staphylococcus were identified. Among the
2 bacteria from the HACEK group, 1 H. paraphrophilus
and 1 Cardiobacterium hominis were identified. PCR per-
formed with a second gene confirmed the previous PCR
results with 1 exception. One Streptococcus sp. was not
retrieved by PCR targeting a second or third gene and was
considered as contamination. The PCR targeting the
18S–28S rRNA ITS allowed the detection of 1 Candida
parapsilosis. Finally, Bartonella spp. were also specifical-
ly visualized in vegetations by immunohistochemistry in
all the cases of B. quintana endocarditis (Figure 3). 
Causative Microorganisms and Discordant Results
The overall distribution of causative microorganisms
and their identification, depending on the diagnostic tools
used, are displayed in Table 2. An etiologic agent could not
be determined for 10 (13%) of definite cases and 28 (76%)
of possible cases. For the 2 patients with recurring infective
endocarditis, the cause for the first episode was different
than that of the second episode. One patient had endocardi-
tis caused by Streptococcus oralis, and 1 year later, endo-
carditis caused by K. kingae developed. For the other
patient, no etiologic diagnosis was established for the first
episode, during which a valve removal was necessary. Four
months after cardiac surgery, the patient had endocarditis
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Figure 2. Western blot performed with a serum sample from a
patient with an endocarditis caused by Bartonella quintana.
Molecular masses (in kilodaltons) are given to the left of the pan-
els. A) Untreated serum sample analyzed with B. quintana (lane
1), B. henselae (lane 2), B. elizabethae (lane 3), B. vinsonii subsp.
arupensis (lane 4), and B. vinsonii subsp. berkhoffii (lane 5) anti-
gens. B) B. quintana-adsorbed serum sample analyzed with B.
quintana (lane 1), B. henselae (lane 2), B. elizabethae (lane 3), B.
vinsonii subsp. arupensis (lane 4), and B. vinsonii subsp. berkhoffii
(lane 5) antigens. C) B. henselae-adsorbed serum analyzed with
B. quintana (lane 1), B. henselae (lane 2), B. elizabethae (lane 3),
B. vinsonii subsp. arupensis (lane 4), and B. vinsonii subsp. berk-
hoffii (lane 5) antigens.caused by Staphylococcus epidermidis. Nine discrepant
results were also observed and are summarized in Table 4.
Discussion
Endocarditis cases with fastidious agents escape micro-
biologic diagnosis classically applied in Algerian laborato-
ries. For the first time, we established a profile of the
microbiologic etiology of infective endocarditis in Algeria.
Our conclusions concerning PCR results were submitted to
a rigorous strategy of validation. All of the controls must
be correct for validating each assay. The result was con-
sidered true if confirmation was obtained by successfully
amplifying bacterial DNA when targeting another gene,
the PCR result was congruent with the results of other
diagnostic tools, or both. 
Of the 77 cases of definite infective endocarditis, the
cause was found for 67 (87%) cases. The diagnosis was
performed on the basis of positive blood cultures for 44
cases. For 20 (26%) cases, no etiologic diagnosis was
obtained in Algeria but was performed in France on the
basis of cardiac valve PCR, and Bartonella and Coxiella
burnetii serologic testing. These data show improvement
in the etiologic diagnosis of endocarditis when molecular
or serologic tools are used. The rate of remaining infective
endocarditis without cause is comparable to the prevalence
in western countries (16). As in other countries, the etio-
logic distribution is dominated by the bacteria responsible
for infective endocarditis, such as Streptococcus spp. and
related genera, Staphylococcus spp., and bacteria from the
HACEK group. The difference in comparison to other
countries is that blood culture–negative endocarditis is
mainly linked to zoonotic and arthropodborne agents. 
For the 33 cases of possible infective endocarditis, the
number of etiologic diagnoses was fewer than those for
definitive infective endocarditis However, in this group,
some cases are infective endocarditis and others are not. If
we consider a Bartonella serologic result >1:800 as a
major criterion (5), the 2 possible cases of B. quintana
infective endocarditis will be classified as definite.
Therefore, Bartonella serologic results should be taken
into account in future revisions of the Duke criteria. Of the
48 case-patients with positive blood cultures, 19 had addi-
tional samples tested through a second analysis (serologic
or molecular methods). Of the 19, 11 had negative results,
5 were concordant, and 3 were discordant. Of these 48 cul-
tures, 1 corresponds to brucellosis. 
Of the 62 blood culture–negative endocarditis cases,
samples from all were tested by serologic or molecular
methods. Of these, 34 were negative, and 28 had an etio-
logic agent identified. Seventeen of those were due to
zoonoses or arthropodborne bacterial diseases. 
Discrepancies were observed between the results ob-
tained by using the various techniques. Some discrepancies
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Figure 3. A) Section of an aortic valve from a patient with
Bartonella endocarditis. Note the extensive fibrosis of the connec-
tive valve tissue (arrowhead), the vegetation (*), and the low
inflammatory infiltrate of the valve tissue (hematoxylin-phloxine-
saffron, original magnification 100x). B) Resected valve with
Bartonella quintana infection showing darkly stained bacilli consis-
tent with Bartonella. Note the numerous clusters of argyrophilic
bacteria present in the valvular vegetation (Warthin-Starry silver,
original magnification 1,000x). C) Immunohistochemical detection
of B. quintana in a resected valve from a patient with Bartonella
endocarditis. Note the extracellular distribution of the bacterial
colonies (*) in the valvular vegetation (polyclonal antibody and
hematoxylin counterstain, original magnification 250x).resulted from culture contamination with the cutaneous
flora. A significant rate of contamination has been already
reported, and the low specificity of valve culture that we
observed confirms these results (23–25). One discrepancy
was caused by identification problems at the species level
for Streptococcus. This fact has been previously reported
(7). Another discrepancy was linked to a Candida species
misidentification by phenotypic analysis, which was cor-
rected by using molecular tools. The last discordant case
corresponded to a patient for whom blood cultures were
positive for H. influenzae. When serum samples were ana-
lyzed, a diagnosis of B. quintana endocarditis has been
established in the presence of positive Bartonella MIF,
Western blot, and PCR. We do not know if B. quintana was
misidentified as H. influenzae, which is possible as both
are slow-growing, hemin-dependent, small, gram-negative
bacteria (26). We believe that as fastidious, small, gram-
negative bacteria growing in blood agar, the 2 organisms
may be confused. 
In Algeria, cases of infective endocarditis caused by
zoonotic and arthropodborne disease agents, such as
Coxiella burnetii,  Brucella melitensis, and Bartonella
quintana are frequently observed and correspond to one
quarter of the performed diagnoses. B. quintana would be
one of the most common agents of infective endocarditis in
our Algiers series (15.6% of definite infective endocardi-
tis). The prevalence of endocarditis caused by Bartonella
varies depends on the country. In Canada, Bartonella caus-
es 3% of endocarditis cases (27). In Sweden, no Bartonella
endocarditis was identified in an analysis of 334 infective
endocarditis cases (28). In the United Kingdom,
Bartonella endocarditis accounts for 1.1% of infective
endocarditis cases (29). In Germany and in France,
Bartonella endocarditis accounts for 3% of all infective
endocarditis (A. Sander et al. unpub. data) (27). The fre-
quency of Bartonella endocarditis is <1% for Sweden and
higher in France, Germany, the United Kingdom (3%), and
North Africa (15%). Such differences may be linked to dif-
ferences in living conditions. 
Homeless people are at risk for B. quintana endocardi-
tis (30,31). Indeed, B. quintana, like  Rickettsia
prowazekii, the agent of epidemic typhus, is transmitted
by body lice. Those who live in extreme poverty are often
the persons who are infested. The recent description of
typhus in Algeria confirms that poor socioeconomic con-
ditions still exist in this country (32–34). In our studies, B.
quintana endocarditis cases occurred in patients living in
poor conditions. Although the only known reservoir for B.
quintana is humans, the bacterium has recently been asso-
ciated with fleas (35). Moreover, some cases of B. quin-
tana infections have been linked to contact with cats and
cat fleas in patients who were not homeless and did not
have body lice (36). 
Brucella melitensis, well known in northern Africa,
where bucellosis is endemic in certain areas, accounts for
2.6% of all infective endocarditis cases for which an etio-
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netii detection requires specialized tests not normally
found in most laboratories, it is not often diagnosed in
Algeria (38). Two cases were retrospectively detected. 
Importance of infective endocarditis caused by zoonot-
ic and arthropodborne agents in Algeria leads to 2 consid-
erations. First, specific serologic tests need to be used for
diagnosis. Indeed, 25% of our etiologic diagnoses corre-
spond to microorganisms for which the diagnosis is usual-
ly based on serologic testing. Secondly, the therapeutic
impact of Brucella and  Coxiella diagnosis is important
because the antimicrobial treatment of endocarditis caused
by these agents must include doxycycline. The 2 patients
with Q fever endocarditis died during their hospitalization
because of inadequate antimicrobial therapy. Finally, the
high rate of blood culture–negative endocarditis was not
linked to prior antimicrobial therapy but rather to fastidi-
ous microorganisms for which serologic testing (as for
zoonotic and arthropodborne disease agents) or molecular
analysis (as for Mycoplasma hominis [39] and
Corynebacterium spp.) are diagnostic tools. 
Our study underlines the need to perform serologic
analysis to determine for the etiology of infective endo-
carditis. Bartonella serologic testing is an important tool
for diagnosis of blood culture–negative endocarditis and
should be taken into account in future revisions of the
Duke criteria. This study made it possible to show that
zoonotic and arthropodborne disease agents cause one
quarter of infective endocarditis in Algeria; B. quintana
caused 13% of our cases. 
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